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1. Introduction    
In the post-genomic and proteomic era, there is a better understanding of important 
physiological components such as DNA, RNA, proteins and small biological molecules, all 
of which have proven to be the mediums of disease progression. Identification and 
investigation of disease-specific biomarkers in the initial stage of a disease can greatly 
increase accuracy in diagnosis, treatment and even prevention. This approach offers great 
potential to significantly reduce disease-related mortality rates.  There is an increasing need 
in the medical field for rapid, cheap and reliable diagnostic systems in order to detect all the 
well-known and recently identified biomarkers for different diseases. This identification is 
not a trivial exercise because these disease biomarkers are present in minute quantities in 
physiological conditions such as the bloodstream or body fluids, which are often 
contaminated with many other compounds that can hinder detection. Apart from biomarker 
diagnosis, another area of concern for human health has been food contamination. Trading 
of contaminated food between countries and high population mobility increases the 
potential for outbreaks and health risks posed by microbial pathogens and toxins in food. 
Food safety has become a global health goal. Periodic toxin and microbiological analyses of 
food samples are important to diagnose and prevent problems related to health and food 
safety. However, food-borne pathogens are mostly present in very low numbers among 
various other microorganisms, making their detection difficult. To be able to detect these 
disease carriers and biomarkers in their natural conditions, highly sensitive as well as 
specific recognition elements are required. It is necessary to develop detection techniques 
that are reliable, fast, easy, sensitive, selective, cost-effective and also suitable for real time, 
in situ monitoring. Such techniques to detect pathogens and biomarkers would not only 
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improve clinical success rates but also offer a great commercial advantage to the medical 
field and the food industry. 
Conventional techniques for the detection of disease biomarkers, pathogens and toxins are 
immunology-based methods, polymerase chain reaction (PCR) based methods and culture 
and colony counting methods. Though these standard detection methods are sensitive, they 
lag behind in terms of detection time, taking from several hours to days to yield a response 
(Velusamy et al. 2010). Conventional analytical techniques like optical, chromatographic and 
electrochemical detection are faster, but have some limitations of equipment and cost. 
Furthermore, they are complicated and require highly trained personnel and extensive 
sample preparation. These constraints do not always allow frequent, real time or in situ 
monitoring of food or clinical samples. Thus, demands of high sensitivity, specificity, cost-
effective, portable and rapid analyses have propelled the development of biosensors as 
novel diagnostic tools in the medical and food sectors.  
Many diagnostic tools still rely on immunoassays and especially enzyme-linked 
immunosorbent assay (ELISA). Besides these classical tests, several phage and aptamer 
based sensors have also been proposed for a broad range of disease biomarkers or carriers 
such as antibodies, viruses, disease-related proteins, tumour cells, toxins and pathogens, 
among several others. The precise detection of these biomarkers or carriers before the onset 
of a disease can significantly revolutionise the medical field by providing cheap, fast, simple 
and easily produced diagnostic tests using phages and aptamers as their recognition 
elements. The wide range of assays that employ phages or aptamers to detect important 
clinical molecules, highlights the potential of these new receptors in clinical diagnostic tests 
and in food biosensors.  
This chapter will define phages and aptamers and discuss their use as novel biorecognition 
elements in biosensors. We discuss two relevant cases in the field of biosensors: the use of 
diagnostics for clinical testing and the use of biosensors for food-related testing.  
2. Biosensors 
A biosensor is defined by the IUPAC as a self-contained integrated device that is capable of 
providing specific quantitative or semi-quantitative analytical information using a biological 
recognition element (biochemical receptor), which is retained in direct spatial contact with a 
transduction element.  
Biosensors can be categorised by the type of recognition element used, such as enzymatic, 
whole cell or affinity-based biosensors. Enzymes are proteins that catalyse specific chemical 
reactions and were the first molecular recognition elements to be included in biosensors. 
They are attractive sensor recognition elements because their use can convert the analyte 
into a sensor-detectable product, evaluate the modification of enzyme properties upon 
interaction with the analyte or detect an analyte that acts as the enzyme inhibitor or 
activator. In fact, the most widely studied and acclaimed sensor success story is that of the 
glucose biosensor, an enzymatic sensor (Newman & Turner 2005; Wang 2007). Whole-cell 
biosensors, the next classification of biosensors, often use a genetically engineered cell of 
either eukaryotic or prokaryotic origin, containing responsive transcriptional promoter 
elements as the biological component. These whole cell biosensors are used for the profiling 
of the toxicological effects of compounds and for risk assessment of chemical contaminants 
or of new compounds (Robbens et al. 2010). The third type of biosensors which are of higher 
relevance for diagnostics, are affinity-based biosensors. In these, the affinity-based receptor 
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molecule binds the analyte irreversibly and non-catalytically. The binding event between 
the target molecule and the bioreceptor, triggers a physicochemical change that can be 
measured by a transducer. In order to ‘visualise’ the binding event, the different 
transduction methods that are frequently used in these biosensors are optical, 
electrochemical or mass-based.  
When the detection system requires a biomolecular recognition event, antibody-based 
detection methodologies are considered the standard assays in clinical analysis (Aizawa 
1994; Stefan et al. 2000). These assays are well established and have been demonstrated to 
reach the required sensitivity and selectivity. However, the use of antibodies in situ 
detection methods and in the analysis of very complex samples could encounter some 
limitations mainly deriving from the nature and synthesis of these protein receptors. 
Antibodies are relatively cheap, but their production relies on the immune response of an 
animal. Besides the ethical problems related to the use of animals, it is also difficult to 
generate antibodies for toxic compounds or small compounds that cannot elicit an immune 
response. In order to avoid some of these drawbacks, recent advances in biotechnology, 
nanotechnology and surface chemistry offer the possibility of developing other novel, 
affinity-based recognition molecules that have been explored as alternatives to the 
traditionally used antibodies. This is a domain in which phages and aptamers can play a 
successful role. They have emerged as viable options thanks to their high selectivity and 
affinity towards their targets, comparable to that of antibodies. The high affinity and hence 
high sensitivity, high specificity, robustness, animal-friendly production and ease of 
modification are some of the defining properties that make the use of aptamers and phages 
advantageous in diagnostic and biosensing tools (Van Dorst et al. 2010b).  
3. Phages     
Phages are viruses that use their host bacterial cells as factories for their own replication and 
have the ability to display peptides or proteins on their surfaces. This technology is called 
phage display. Phage display can be used as a powerful tool to screen for affinity reagents 
for all kind of targets, ranging from small molecules to proteins and even cells. This 
selection can be performed by using phage libraries consisting of a high number of different 
phages (108 - 1010), each displaying a different peptide or protein on its surface. Among the 
huge number of phages in these phage libraries, the ones with high affinity and specificity 
for a target can be isolated in an affinity selection procedure (Fig. 1). Moreover, the proteins 
and peptides displayed on these selected phages can be identified by sequencing the gene 
coding for the displayed protein or peptide. This coding gene can be found in the single-
stranded DNA (ssDNA) inside the selected phage. The target specific phages can be used as 
affinity reagents in diagnostic tests. Besides the target specific phages, the soluble peptides 
or proteins, released from the phage coat, can also be used as affinity reagents. These 
peptides or proteins are then produced synthetically or by recombinant expression in 
bacterial cells. 
Different types of phage libraries exist, displaying different types of peptides or proteins: 
peptides, cellular proteins (from cDNA libraries) or antibody fragments, like single chain 
variable fragments (scFv) and antigen binding fragment (Fab). Antibody fragment phage 
libraries are used commonly in immunology (Hoogenboom et al. 1998). Their wide 
diversity enables them to imitate the natural immune system. Phage display enables the 
production of sizeable amounts of the affinity reagents, avoiding the batch to batch 
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Fig. 1. Schematic representation of the phage affinity selection procedure (Van Dorst et al. 
2010a)  
variations which occur with classical antibodies. Moreover, there is no immune response 
required to produce affinity reagents for a target, making the selection of affinity reagents 
for poorly immunogenic targets possible. Peptide phage libraries can also be used to select 
affinity reagents, since the binding site, or epitope, only involves a few amino acids. Besides 
the monovalent phages that display one peptide on the phage surface, so-called landscape 
phages are also used as affinity reagents. These landscape phages display thousands of 
copies of peptides in a dense, repeating pattern around the tubular capsid (Petrenko & 
Smith 2000). The display of these thousands of peptides gives the phage surface different 
characteristics. The binding affinity of the landscape phages for the target is not determined 
by the affinity of one of these peptides alone, but by the whole structure.  In cDNA phage 
libraries, cellular proteins are displayed on the surface of the phages. These cDNA phage 
libraries are frequently used for protein interaction studies (Crameri & Kodzius 2001; 
Pelletier & Sidhu 2001; Li & Caberoy 2010; Van Dorst et al. 2010c). Furthermore, they can be 
used as affinity reagents in diagnostic tests to detect antibodies for cellular proteins and to 
diagnose autoimmune diseases. 
4. Aptamers 
Aptamers are small sequences of nucleic acids, RNA or DNA, and more rarely peptide 
chains, able to specifically recognise a given target, ranging from small molecules to entire 
organisms (bacteria). The term aptamer derives from the Latin word aptus meaning fitted or 
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suitable, and the Greek word meros meaning part or portion, referring to the folding 
properties of single-stranded nucleic acids, responsible for their specific tridimensional 
structure. This hairpin structure can bind targets so tightly that some aptamers can even 
differentiate between two isomers, or closely related molecules. For instance, an aptamer 
selected for theophylline has shown that its binding affinity was 10,000-fold more important 
for theophylline than caffeine, only differing in structure by a methyl-group (Jenison et al. 
1994). In this application of nucleic acids in biotechnology, the recognition is based on the 
tridimensional structure of the aptamer, more than its sequence. Aptamers undergo 
significant conformational changes upon target binding, thus offering great flexibility in 
design of novel biosensors; for instance, being formatted into molecular beacon structures 
(Yamamoto et al. 2000a).  
Aptamers are selected from synthetic nucleic acid libraries which can contain more than 1015 
different sequences, by an in vitro selection procedure commonly called SELEX, an acronym 
for Systematic Evolution of Ligands by EXponential enrichment (Stoltenburg et al. 2007). 
This iterative process consists of binding and elution steps of aptamers in contact with the 
molecule or organism of interest, copying the resulting aptamers by using PCR and finally 
separating the two strands obtained after the polymerisation (Fig. 2). After each cycle, the 
pool is enriched and used for the next selection cycle, until the amount of eluted aptamers 
reaches 80 to 90% of the initial amount of the pool. Usually, eight to fifteen selection cycles 
are needed to isolate aptamers with a high binding potential. Once a specific aptamer is 
selected for a target, this recognition element can be integrated into a transducing structure 
or device, in order to construct a biosensor. 
 
 
Fig. 2. Selection of aptamers via SELEX procedure (Van Dorst et al. 2010b) 
5. Advantages and limitations of phages and aptamers 
The use of both, phages and aptamers, as affinity reagents in diagnostic tests have some 
distinct advantages: 
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• High sensitivity and specificity for targets 
Phages and aptamers are selected from their respective libraries which have a very wide 
diversity, even higher than that of antibody repertoires screened with the hybridoma 
technique. Strong selection conditions and counter selections with related targets result in 
specific binding phages and aptamers with high affinity. Moreover, the sensitivity and 
specificity of the selected phages can be increased with genetic modification (Sheedy et al. 
2007). On the other hand, the selection process for aptamers can be directed to recognise 
specific structural or chemical motifs of the target, which is not always possible with 
antibodies. Phages and aptamers can both recognise their targets in ranges below nanomolar 
amounts, sometimes even down to picomolar ranges (Collett et al. 2005; Zhu et al. 2008).  
• Fast, inexpensive and animal-friendly production  
Phages are produced by infecting bacteria, a process which takes only a few hours and no 
animals need to be immunised; nucleic acid production is completely animal-free too, as it is 
chemically synthesised on a large scale. Thus both techniques avoid batch-to-batch 
variations, are very cost-effective and are reproducible.  
• Stability 
Phages are stable in a wide variety of conditions:  at high temperatures (Brigati & Petrenko 
2005) and in a wide pH range from 3 to 11 (Jepson & March 2004; Verma et al. 2009). 
Moreover, phages can even resist nucleases or proteases (Schwind et al. 1992). Their high 
degree of stability not only offers technical, but also economic advantages. The degree of 
stability extends the lifetime of diagnostic tests and reduces transport costs by avoiding the 
need for cooled shipment and storage.  
Nucleic acids allow the use of a wide variety of buffers and organic solvents, which can be 
interesting for monitoring organic compounds. Indeed, nucleic acids remain stable in 
hydrogen bond forming solvents such as ethylene glycol, methanol, formamide, dimethyl 
sulfoxide or acetamide (Bonner & Klibanov 2000). As opposed to their protein counterparts, 
aptamers can be selected under nonphysiological conditions or real matrix conditions, 
which is particularly useful for biosensing clinical and food samples. 
• Ease of modification 
Phages are easily modified, because of the accessible amine groups on the phage coat 
protein VIII. Via these amine groups, phages can be immobilised or conjugated to labelling 
molecules (Jin et al. 2009). 
Aptamers can easily bear labels at each end of the strand. For instance, reporter molecules 
such as enzymes or fluorophores, were used in the development of aptamer biosensors 
(Tombelli et al. 2005b). A wide variety of labels can also be used with nucleic acid to be 
immobilised onto different surfaces. Nucleic acid biotinylation is a technique widely spread 
in biotechnologies, based on the strong bond between biotin and avidin (or streptavidin). 
This allows nucleic acids to be fixed to almost any type of streptavidin-modified surfaces, 
which are in many cases commercially available. Alternatively, nucleic acid can be labelled 
with phosphate, amine or thiol moieties enabling a covalent immobilisation of the nucleic 
acid probe. 
• Reusability 
This is an advantage unique to aptamers. Unlike antibodies, aptamers can undergo several 
cycles of denaturation and regeneration. This allows aptasensor platforms to be recyclable 
and reusable. 
Though phage and aptamer technology hold great promise, there are limitations: 
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• Unavailability of standardised protocols: For each new target, specific modifications are 
usually necessary. Moreover, protocols have to be adjusted and parameters often have 
to be optimised before the selection technique offers significant results, for both phages 
and aptamers.   
• Immobilisation of targets: A requirement for phage and aptamer selections is that the 
targets need to be immobilised on a solid support; this is easily achieved for proteins 
and whole cells but is more complex for smaller molecules where specific 
functionalisations are necessary to enable efficient immobilisations. 
• Nuclease sensitivity: Nucleic acids can be degraded in real matrices by the action of 
nucleases. This concern can be overcome by chemical modification of the ribose ring at 
the 2’ position with fluorine or amino groups. Another technique consists in using 
mirror-image analogues, called spiegelmers, which are nuclease resistant (Eulberg & 
Klussmann 2003) 
6. Applications of phages 
6.1 Medical diagnostics 
6.1.1 Autoantibody detection in diseases characterised by deviations of the immune 
system  
cDNA and peptide phage display are applicable for epitope mapping of monoclonal or 
polyclonal antibodies. In medical practice, this epitope mapping approach has potential 
value in the profiling of circulating antibodies in diseases characterised by immune system 
deviations, such as cancer and autoimmune disorders; the analysis of circulating antibodies 
allows the identification of immune-targeted tumour antigens in cancer and auto-antigens in 
autoimmunity. Depending on the affinity selection approach employed, disease-specific 
circulating antibody reactions can be used as diagnostic markers, as markers for prognosis 
and therapeutic outcome, and as markers for therapeutic responsiveness. The selected 
peptide or protein displaying phages can be used in diagnostic tests to detect disease-
associated or disease-specific antibodies. Moreover, the identified antibodies and associated 
antibody-targets can be important for the discovery of novel therapeutic targets in cancer 
and autoimmunity research. 
Serological antigen selection (SAS) is a phage display-based autoantibody profiling 
approach in which a cDNA expression library from diseased tissue or cell-lines is displayed 
at the surface of phage particles, followed by affinity-selection with pooled patient 
antibodies (Fig. 3). This procedure has recently been successfully applied for colorectal 
cancer (CRC) (Somers et al. 2002), atherosclerotic lesion rupture (Cleutjens et al. 2008), and 
multiple sclerosis (MS) (Somers et al. 2008; Govarts et al. 2009).  
The SAS procedure entails subsequent rounds of affinity selection of a cDNA phage display 
library with patient immunoglobulins. An affinity selection round is initiated by incubating 
phage displaying the cDNA library with pooled patient body fluids (1). During this 
incubation step, antigen-antibody complexes are formed between the antibodies present in 
the patient body fluids and their respective target antigens at the surface of the phage (2).  
These complexes are captured on a solid support by anti-human IgG capture antibody (3) 
while non-bound phages are washed away (4). Bound phages are eluted (5), amplified 
through infection of host bacteria (6) and used as input in a subsequent affinity selection 
procedure (7). The succession of affinity selection and amplification of selected phages 
results in enrichment op phage displayed antigens targeted by patient IgG. 
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Fig. 3. Overview of the serological antigen selection (SAS) procedure 
The SAS technology was initially developed to discover novel candidate tumour-antigens 
for CRC. In this study, the procedure was applied on a cDNA expression library from CRC 
cell line HT-29 using pooled CRC patient serum. Six phage clones with a CRC-related 
serological profile were identified, making excellent candidates for tumour vaccination and 
sero-diagnosis of cancer (Somers et al. 2002).  
For the identification of novel markers for ruptured atherosclerotic lesions, SAS was 
performed on a cDNA expression library prepared from mRNA preferentially expressed in 
ruptured human atherosclerotic plaques. Sera from patients with ruptured atherosclerotic 
plaques were used for selection of phages expressing immunoreactive fusion proteins 
resulting in the identification of two phage clones. The presence of antibodies against the 
peptides displayed by these clones could discriminate between patients with peripheral 
ruptured lesions and patients with peripheral stable plaques with 100% specificity and 76% 
sensitivity. A positive serum response against a set of two novel identified cDNA phage 
clones thus showed a strong association with the presence of ruptured peripheral 
atherosclerotic lesions, allowing a promising novel approach for non-invasive diagnosis of 
atherosclerotic lesions (Cleutjens et al. 2008). 
In another study, the use of the SAS procedure on a cDNA expression library from MS brain 
tissue and selection on pooled cerebrospinal fluid (CSF) of MS patients has led to the 
discovery of eight novel phage clones and associated autoantibody reactions with 45% 
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sensitivity and 86% specificity for the disease. As currently the diagnosis of MS is largely 
based on clinical symptoms, the implementation of objective laboratory tests that can 
measure the serological presence of the markers can be of great value to MS diagnostics. 
Moreover, the analysis of the MS-associated immune deviations through autoantibody 
profiling is also valid to provide the urgently needed clues regarding disease-associated 
autoantibody-targets and the underlying autoimmune aetiology (Somers et al. 2008; Govarts 
et al. 2009).  
Phage-based biosensor platforms that incorporate the novel identified cDNA phage clones 
can be developed for serological screening of patients, resulting in clinical application of 
these phage clones in medical diagnostics. 
6.1.2 Serum diagnosis of infectious disease by detection of antibodies with a phage-
particle gel immunoassay (PPaGIA) 
Infectious diseases are a matter of national security and may have a great impact on public 
health and the world economy, especially due to rapid dissemination and adaptation of 
pathogens. Proper diagnosis of infectious diseases with reliable, robust and sensitive tests is 
very important for individual health, but is also crucial for surveillance and control of 
infectious diseases worldwide. One possible diagnosis of infectious diseases is the detection 
of pathogen-specific antibodies in the blood or serum of patients. Phages are very 
appropriate for the development of these antibody detection tests. Peptide phages 
displaying a peptide that mimics the antigen (mimitope) and binds to antigen-specific 
antibodies, can be selected. Peptide phage display is already widely used for epitope 
mapping of poly- and monoclonal antibodies (Irving et al. 2001). However, the selected 
peptide phages that bind to pathogen specific antibodies in these studies can also be used in 
diagnostic tests to detect these pathogen-specific antibodies. Goulart et al. (2008) developed 
a phage-particle gel immunoassay (PPaGIA), which uses polystyrene beads conjugated with 
peptide phages with affinity for pathogen-specific antibodies. When pathogen-specific 
antibodies are present in blood or serum of infected patients they will bind to the beads 
conjugated with these peptide phages. These antibody-bead complexes can be separated by 
size from the beads that do not interact with the antibodies, by centrifuging through a gel 
matrix of chromatographic microcolumns. When antibody-bead complexes are formed, they 
are captured at the top of the column, in contrast with plain beads that will be detected at 
the bottom of the column after centrifuging. An example of leismaniasis diagnosis with 
PPaGIA is visualised in Fig. 4.  
6.1.3 Metastatic cell detection 
Metastasis is the spread of cancer from the place at which it starts as a primary tumour to 
other tissues in the body. An early detection of metastasis is important for early treatment of 
cancer, which increases the chances of a cure. The current diagnosis of metastasis is only 
possible by a series of biopsies in different tissues. However, biopsy is an invasive approach, 
which is not applicable in the early stage of metastasis and less applicable if patients do not 
have a clearly defined pathological site (Aggarwal et al. 2005). A promising alternative for 
metastasis diagnosis is the measurement of tumour cells in the blood, because the metastatic 
tumour cells are loosened and released into the blood or lymph. For the development of 
diagnostic approaches to detect metastatic tumour cells in blood, affinity reagents selective 
for metastatic markers, unique to tumours are required. Here, phage display can be used. A 
number of peptides that bind specific metastatic tumour cells are identified by differential  
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Fig. 4. Digital image of the PPaGIA. Circulating antibodies from leismaniasis patients were 
detected with peptide phages that specifically recognise antibodies for visceral leismaniasis 
(VL). A: positive serum from a patient with VL detected with specific phages (agglutination 
at the top); B: positive serum from a patient with cutaneous leismaniasis (CL) probed with 
specific phages (no reaction); C: positive serum from a patient with VL probed with 
nonspecific phages (no reaction); D: negative serum probed with specific phages  
(no reaction). (Goulart et al. 2010) 
screening with phage display (Rasmussen et al. 2002; Jia et al. 2007; Rittner et al. 2007; Zhang 
et al. 2009). The selected metastatic specific peptide phages can be used to develop a 
diagnostic approach to detect metastatic cells in blood samples. Zhang et al. (2009) 
developed a light-addressable potentiometric sensor (LAPS), that measures the surface 
potential of an illuminated sensor chip. The metastatic-specific peptide phages are 
covalently coated on the sensor chip of this LAPS, as visualised in Fig. 5. 
The blood sample is injected in the microchamber and metastatic cells are captured by the 
immobilised phages. This capturing of metastatic cells causes changes in surface potential, 
which is measured and translated in an output voltage with the lock-in amplifier. With this 
LAPS modified with metastatic-specific peptide phages, it was possible to distinguish 
between metastatic cells and non-metastatic cells and detect as few as 100 metastatic cells 
per ml. This approach shows the potential of peptide phage display to develop diagnostic 
approaches for metastatic cancer. 
6.2 Food biosensors 
6.2.1 Salmonella typhimurium detection 
S. typhimurium is one of the leading sources of human gastroenteritis, causing mainly 
diarrhoea, vomiting and abdominal cramps 12 to 72 hours after infection and possibly 
lasting for up to seven days. Humans are usually infected with Salmonella by ingesting 
contaminated food such as raw meat, fish, unpasteurised dairy products and eggs. A 
conventional, accurate way to detect S. typhimurium in food samples can be carried out by 
means of microbiological culture growth techniques. The problem, however, is that the 
results are only obtained within three to five days. For this reason, several rapid DNA-based 
(McGuinness et al. 2009), biochemical, immuno-assay (Beumer et al. 1991) and immuno-
latex agglutination methods have been developed. Mostly, they obtain results within 48 
hours. Still, faster detection of S. typhimurium is necessary to avoid outbreaks by preventing 
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infected food from being distributed and consumed. Biosensor technology can provide such 
rapid results. 
 
 
Fig. 5. Schematic representation of LAPS modified with metastasis specific peptide phages 
(Zhang et al. 2009) 
A Magnetostrictive Microcantilever (MSMC) was developed as a transducer for the 
development of a biosensor for S. typhimurium by Fu et al (2007). The technology is based on 
applying a time-varying magnetic field, on the cantilever (Fig. 6). A filamentous peptide-
displaying phage against S. typhimurium was used as a biorecognition element, which was 
immobilised on the surface of the cantilever by direct physical absorption. The resonance 
frequency, registered by two pick-up coils connected to a lock-in amplifier to measure the 
electric potential, shifts with time as the target bacterium binds on the sensor surface. The 
resonance characteristics of the MSMC in liquid were studied and the device proved to 
function well in water.    
A similar sensor, based on the application of a magnetic field was built by (Lakshmanan et 
al. 2007) for the detection of S. typhimurium. The phage was derived from a landscape phage 
library. Instead of using a cantilever, a piece of ribbon on which the phages were 
immobilised, was utilised (Fig. 7) and the analyte was passed over the sample using a 
peristaltic pump. A detection limit of 103 cfu/ml was obtained for the sensor. The main 
advantages of these sensors are the sensitive and real-time detection. 
The same approach of detection with magnetoelastic biosensors was used by different 
authors (Wan et al. 2007; Huang et al. 2008; Johnson et al. 2008) for Bacillus anthracis. Olsen 
et al (2006) developed a Quartz Crystal Microbalance (QCM) biosensor for the detection of 
S. typhimurium. QCM sensors are based on the resonation of the quartz crystals on 
application of an external alternation electric field. The frequency of the resulting oscillation 
is a function of the mass of the crystal. When the target binds to the phages, which are 
immobilised on the metallic electrodes on both sides of the piezoelectric quartz crystal, a 
shift in resonance frequency of the quartz crystal occurs. The sensor delivered a rapid 
response (< 180 s) and had a low-detection limit of 102 cells/ml.  
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Fig. 6. Schematic illustration of the principle of MSMC as a transducer for biosensors. (Fu et 
al, 2007) 
  
 
Fig. 7. Scheme illustrating the wireless nature of the magnetoelastic biosensors and the basic 
principle for detecting bacterial cells. The binding of bacterial cells is on both sides of the 
sensor (Lakshmanan et al. 2007) 
6.2.2 Detection of Staphylococcal enterotoxin B (SEB) 
SEB is produced naturally by the Staphylococcus aureus bacterium in improperly refrigerated, 
stored, and handled foodstuffs and is a very common cause of food poisoning. The toxin can 
be ingested or inhaled and can be used as a warfare agent. The clinical signs include 
symptoms such as headache, fever and chills. Depending on the route of exposure, 
additional symptoms can be observed. Ingestion results in nausea, vomiting and diarrhoea 
while inhalation provokes non-productive cough, chest pain and dyspnea. Classical ways of 
detection are mainly based on multiplex PCR (McLauchlin et al. 2000; Mehrotra et al. 2000) 
and immunoassays (Freed et al. 1982; Wieneke 1991), which allow quantitative or qualitative 
measurements in less than 24 hours.  
A peptide displaying-phage for the optical detection of SEB with biosensor technology was 
developed by Goldman et al (2000). The SEB binding phage was selected from a random 
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peptide library and was fluorescently labelled with Cy5 dye to allow detection. The labelled 
phages were among other methods tested in a portable fibre optic biosensor (RAPTOR) (Fig. 
8). Four optical probes, placed in a disposable chamber were coated with SEB or 
streptavidin, and the labelled phage was loaded onto the chamber. The complex formation 
could be monitored by the surface-bound fluorophores with a diode laser. The optical probe 
captures a portion of the emitted fluorescence, which travels back up the fibre to the 
photodiode detector (Anderson et al. 2000). Different laser readings were taken at different 
moments of the one-hour assay. The phage did generate a robust signal however it gave a 
lower signal than that generated by a labelled antibody and the detection of small amounts 
of SEB was problematic. Nevertheless, in optimised forms, this approach has the potential to 
perform at levels comparable to their antibody counterparts. 
 
 
Fig. 8. Schematic of  the RAPTOR showing four fibre optic probes, adhesive channel cover 
and bubble detector mirrors (Anderson et al. 2000) 
7. Applications of aptamers 
7.1 Medical diagnostics 
7.1.1 Electrochemical detection of Platelet-derived growth factor (PDGF) 
PDGF is a protein that regulates cell growth and division (Degefa & Kwak 2008) and is 
believed to be differentially expressed in human cancer (Polanski & Anderson 2006). 
Tumour cell lines produce and secrete PDGF (Famulok & Mayer 1999), thus making it a 
plasma biomarker that could be useful in early cancer detection and monitoring. This 
growth factor also participates in other proliferative disorders such as glomerulonephritis 
(Iida et al. 1991) and arteriosclerosis (Lindner et al. 1995; Lindner and Reidy 1995). Green et 
al (1996) identified DNA aptamers binding to PDGF (AB and BB variants) with 
subnanomolar affinity and which inhibit the mitogenic effects of PDGF. Using the highest 
binding aptamer, Lai et al. (2006) fabricated and characterised an electrochemical, aptamer-
based (E-AB) sensor for the detection of PDGF directly in blood serum. The E-AB approach 
uses alternating current voltammetry to monitor target induced folding in a methylene blue 
(MB)-modified, PDGF binding aptamer. The E-AB sensor is constructed by attaching a MB-
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modified, PDGF-binding aptamer to a gold electrode via self-assembled monolayer 
chemistry. In the absence of its target (Fig. 9, left), the aptamer is thought to be highly 
dynamic and partially unfolded, retaining only one of the three stems intact. This reduces 
electron transfer between the electrode and the MB. Upon target binding (Fig. 9, right), the 
aptamer folds into a configuration, forming a stable three-way junction, forcing the MB label 
into close proximity with the electrode, leading to improved electron-transfer efficiency. 
 
 
Fig. 9. E-AB-based PDGF sensor fabricated by a MB-labelled aptamer on a gold electrode 
surface (Lai et al. 2006) 
This E-AB sensor combines the unprecedented sensitivity, selectivity and reusability of 
aptamers in a single approach, enabling it to detect physiologically relevant PDGF levels 
directly in largely unprocessed clinical samples, for the first time. It readily detects the BB 
variant of PDGF till 1 nM directly in undiluted blood serum and at 50 pM in serum-diluted 
two-fold with aqueous buffer. The detection limit attained in 50% serum is achieved against 
a >25 million-fold excess of contaminating blood proteins and represents a four order of 
magnitude improvement over the most sensitive optical PDGF aptasensor reported to date 
(Fang et al. 2001).  This detection limit enables the sensor to easily measure 400-700 pM 
serum PDGF concentrations, from low levels found in healthy individuals to higher 
concentrations in cancer patients (Leitzel et al. 1991).  The E-AB sensor’s selectivity was 
studied using two control sequences sharing similar sequence identity and similar structure 
to the PDGF binding aptamer, respectively. However, both these sequences exhibited an 
insignificant signal increase (< 1%) under the same experimental conditions. Furthermore, 
the E-AB sensor is reusable and could be used and regenerated up to five times before 
unacceptable degradation was observed. Additionally, as an electrochemical sensor, the E-
AB platform does not require light sources, high-voltage power supplies, or other heavy, 
cumbersome equipment. Given these advantages, E-AB sensors appear well suited for 
implementation in portable convenient point-of-care diagnostics, enabling direct detection 
of proteins and small molecules in complex, unprocessed clinical samples.  
7.1.2 HIV -1 Tat protein detection using  molecular beacon aptamer 
Transcription of human immunodeficiency virus type-1 (HIV-1) is enabled via cellular 
factors and viral proteins (Gaynor 1992). Trans-Activator of Transcription (Tat) is an HIV-1 
RNA-binding protein that exhibits an inherent affinity against the Trans-Activating 
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Response Element (TAR) of the virus and regulates viral transcription (Tombelli et al. 
2005a). For HIV-1, oligonucleotides have been isolated that can efficiently interrupt essential 
steps in the viral life cycle, opening up the potential of treating viral diseases with aptamers 
(Famulok & Mayer 1999). A novel RNA motif  that binds efficiently and specifically to the 
HIV-1 Tat protein and inhibits the trans-activation by Tat of transcription in vitro and in vivo, 
has been selected (Yamamoto et al. 2000b). This aptamer featured a similar structure to TAR 
and exhibited a 133-fold increased affinity for Tat, compared to TAR. Moreover, the aptamer 
does not require a cellular protein for efficient binding to the Tat, unlike the TAR of HIV-1. 
Hence the aptamer is not only useful for inhibiting the Tat function in vivo but also serves as 
a diagnostic reagent for the detection of Tat. 
 
 
Fig. 10. Schematic representation of molecular beacon aptamer strategy for analysing the 
viral protein (Tat). (Yamamoto et al. 2000a) 
To make a diagnostic test using a new molecular beacon aptamer, Yamamoto et al. (2000a) 
split the duplex aptamer  into two RNA oligomers (Fig. 10). One of the split RNA oligomers 
(F-BA1-D), was designed to form a hairpin structure containing a fluorophore (fluorescein) 
and quencher (DABSYL) one at each end of the RNA strand and the other, DA-2, was a non-
structured oligomer. It was observed that in the presence of Tat or its peptides (100 nM), the 
two oligomers underwent a conformational change to form a duplex that lead to relieving of 
fluorophore from the quencher, and thus a significant enhancement of the fluorescence of 
fluorescein, followed by the stabilisation of the ternary complex (Fig. 10). These results 
suggest that splitting of the aptamer into two oligomers does not affect the affinity of the 
oligomers to the Tat, as long as they possess the core binding sequence. 
The molecular beacon aptamer (F-BA1-D) described here does not depend on the target 
sequence (DA-2) alone, but also depends on the target molecule (Tat protein of HIV) other 
than the nucleic acid.  
As a specificity check, other RNA binding proteins were tested, but none of them enhanced 
the fluorescein intensity of the beacon aptamer. Thus the beacon aptamer responds 
specifically to the Tat protein or its peptides and is indeed suitable for specific detection of 
Tat protein, derived from either HIV-1 or HIV-2. Such a molecular beacon aptamer could 
find applications as an analytical tool for monitoring viral protein levels, both in vitro and in 
infected cells (such as HIV infected cells).  
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7.1.3 Mass based detection of Human IgE 
An application of aptamers in biosensors was reported by Yao et al. (2009) to quantify 
immunoglobulin E (IgE), an antibody produced by the immune system under allergic 
reactions. A person who has an allergy usually has an elevated level of IgE in blood, 
therefore the quantification of IgE can considerably ease the clinical diagnosis of allergy-
mediated disorders (Gokulrangan et al. 2005). Although the detection of IgE was already 
possible thanks to methods such as radioimmunoassay (RIA) or enzyme-linked 
immunosorbent assay (ELISA) (Peuravuori & Korpela 1993; Ollert et al. 2005), this 
aptasensor offers a fast and cheap detection method requiring less serum sample and 
reagents. The use of this aptamer as a recognition element of the sensor enables detection of 
concentrations as low as 2.5 µg/L of IgE in buffer and serum 
In this sensor, a 5’-biotin modified nucleic acid aptamer has been fixed to an avidin 
modified gold layer of a quartz crystal microbalance device (QCM), providing a strong 
immobilisation of the recognition element. The piezoelectric sensor generates a frequency 
shift during the formation of the complex made by IgE and the aptamer. A linear 
relationship between the frequency (Hz) and the concentration of IgE has been observed, 
following the regression equation: 
 y = 1.03x – 0.06 (1) 
with x, the frequency, and y, the concentration of IgE in the range of 2.5-200 µg/l, the 
equation having a correlation coefficient of 0.996. 
After the analysis of a sample, this piezoelectric aptasensor could be regenerated with 30 
mmol ethylenediaminetetraacetic acid (EDTA) and reused ten times with the same chip 
without loss of function. 
Finally, this piezoelectric biosensor showed a high specificity when tested with interfering 
proteins such as IgG or bovine serum albumin (BSA), which generated an insignificant 
frequency shift lower than 5% of the signal obtained for IgE. 
7.1.4 Detection of insulin 
Another example of application of nucleic acid aptamers in biosensors can be represented 
by the sensing of insulin by an aptameric enzyme subunit (AES) (Yoshida et al. 2009). 
Insulin is a key molecule in the regulation of glucose in blood (Khan & Pessin 2002). The 
concentration of insulin is lowered in patients suffering from type-1 diabetes because of a 
reduced production of this hormone. Therefore, sensing the concentration of insulin in 
blood or serum can help the detection of type-1 diabetes.   
The AES is constructed by connecting an enzyme-inhibitor aptamer to a target molecule-
binding aptamer, where thrombin is the enzyme (Fig. 11). In the presence of insulin, a 
structural change of the aptamer occurs, preventing the hybridisation to the enzyme-
inhibitor aptamer. This results in activating the enzymatic activity of thrombin to degrade 
fibrinogen, present in the chip. The presence of insulin generates clotting of fibrinogen and 
can be monitored by this sensor. 
7.2 Food biosensors 
7.2.1 Detecting Campylobacter jejuni using fluorescent assays 
An infection by C. jejuni is the most commonly reported cause of acute bacterial-mediated 
food poisoning. The disease is generally mild, but complications such as the Guillain Barré 
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Fig. 11. Scheme of the AES-based insulin sensing. The target molecule-binding aptamer and 
a portion of its complementary strand were attached to the split thrombin-inhibiting 
aptamer. The nucleic acid aptamers are separated in the presence of insulin (Yoshida et al. 
2009) 
syndrome can occur. Remarkably, C. jejuni does not express a large number of so-called 
classical virulence factors. Additionaly, the role of the only verified Campylobacter toxin 
identified (cytolethal distending toxin) in C. jejuni has not been determined yet. The 
conventional culture detection method is time-consuming, while the more recent real-time 
PCR methods allow rapid and more reliable detection of the Campylobacter species. Bonjoch 
et al. (2010) used the gene encoding the ATP-binding protein CJE0832 to detect C. jejuni in a 
real-time PCR approach. Generally, even PCR-based methods need enrichment culturing to 
reach the desired detection limits. 
Stratis-Cullum et al. (2009b) used the entire heat-killed C. jejuni cells as the selection target. 
A capillary electrophoretic assay was developed to investigate the relative binding affinity 
of C. jejuni aptamers. Fig. 12 illustrates the separation of the aptamer-bacterial cell complex, 
monitored by the emission of fluorescent labelled analytes at 520 nm. Migration depends on 
separation medium, size and shape of species, net charge on species and strength of electric 
field. The aptamer probe investigated, exhibited a pronounced mobility shift upon binding 
to the C. jejuni target, while a minimal response was obtained for two other food pathogen 
targets.  
Bruno et al. (2009) developed DNA aptamers against the surface proteins of C. jejuni. The 
aptamers were used in a magnetic bead (MB) and red quantum dot (QD)-based sandwich 
assay, and the reactivity with bacterial species was evaluated with a spectrofluorimeter (Fig. 
13). In this application the use of plastic cuvette-adherent technology improves detection of 
pathogens.  
7.2.2 Electrochemical detection of Botulinum Neurotoxins  (BoNTs)  
Neurotoxins produced by Clostridium botulinum are among the most poisonous substances 
known. Food-borne botulism is the most common intoxication form due to the ingestion of 
pre-formed BoNT in food. The gold standard method to confirm the presence of BoNT 
consists of immunoassays, which are expensive, labour-intensive and slow. Recently, 
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alternative rapid methods, such as quantitative real-time PCR assays, have been developed 
for the detection of C. botulinum (Kirchner et al. 2010; Satterfield et al. 2010). Brunt et al. 
(2010) developed a sensitive and rapid immunochromatography column-based test for the 
detection of  BoNTs.  
 
 
Fig. 12. Schematic representation of the capillary electrophoretic analysis of aptamer: 
bacterial cell complexes using laser-induced fluorescence detection  
 
 
Fig. 13. Illustration of the self-assembling plastic-adherent aptamer-MB and aptamer-QD 
sandwich assay and magnetic collection system (Bruno et al. 2009) 
Recently, Wei and Ho (2009) reported an electrochemical biosensor using an aptamer, which 
could measure BoNT with a limit of detection of 40 pg/ml. The nucleic acid aptamers were 
selected via micro-bead SELEX procedure and their dissociation constants were determined 
to range between 3 nM and 50 nM, representing a quite good affinity towards BoNT. When 
binding to BoNT, a conformational change of the chosen aptamer was used for BoNT 
monitoring (Fig. 14). A fluorescein label has been attached to one end of the aptamer in such 
a way that the label is hidden by the aptamer in the absence of the target. When BoNt is 
present in the sample, the aptamer unfolds and exhibits the fluorescein label, which can 
bind to an anti-fluorescein antibody linked to an enzyme, horseradish peroxidase (HRP), 
reducing hydrogen peroxide and oxidising tetramethylbenzidine (TMB); thus generating an 
electrochemical current signal due to the redox cycles between TMB, HRP and hydrogen 
peroxide. The specificity of the sensor has been proved by testing interfering proteins, which 
did not generate any electrochemical current, showing that the aptamer remained folded in 
the absence of BoNT. 
www.intechopen.com
The Use of Phages and Aptamers as Alternatives to Antibodies in Medical and Food Diagnostics 
 
463 
 
Fig. 14. Scheme of aptamer-based electrochemical detection of Botulinum neurotoxin (BoNT) 
(Wei and Ho 2009) 
8. Conclusions 
Phages and aptamers have great potential as specific recognition elements in various 
biomedical and food applications. Their function as sensing receptors offers advantages 
over methods that are based on antibodies:  their efficient immobilisation, the possibility of 
using different detection methods due to easy labelling and the easy regeneration of their 
functionality after immobilisation. Additionally, they can be modified, thus enhancing their 
stability, affinity and specificity and facilitating the functionalisation of nanoparticles and 
surfaces. These advantages enable the phage and aptamer biosensors to meet the 
requirements of sensitivity and stability that are necessary for the detection of disease 
biomarkers and food contaminants in their natural matrices. 
The full potential of these novel biomolecules has not yet been realised completely and there 
are certain challenges that need to be overcome. However, proof-of-concept experiments 
demonstrating that aptamers and phages can specifically bind and regulate the function of 
various biomedically relevant targets, hold promise for the development of innovative 
diagnostics. The ability to develop affinity-based detection systems consisting of tailor-made 
characteristics, which can be applied to the analyses of disease biomarkers or carriers which 
are unlimited by size, complexity, toxicity and matrix effects, offers the field of biosensing 
the opportunity to explore new and dynamic routes of diagnostic sensor development. 
Overall, the potential of aptasensors and phage sensors is vast, and this exciting area of 
investigation is on the verge of exponential growth. 
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